Abstract
Fasting plasma and urinary amino acid concentrations were studied under carefully controlled conditions in 22 children with Down's syndrome and in age matched controls. The only significant difference between the groups was a higher mean plasma lysine concentration in Down's syndrome patients compared to controls.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Lejeune J., Rethoré M. O., de Blois M. C., Maunoury-Burolla C., Mir M., Nicolle L., Borowy F., Borghi E., Recan D. Métabolisme des monocarbones et trisomie 21: sensibilité au méthotrexate. Ann Genet. 1986;29(1):16–19. [PubMed] [Google Scholar]
- Lejeune J., Rethoré M. O., de Blois M. C., Peeters M., Naffah J., Megarbane A., Cattaneo F., Mircher C., Rabier D., Parvy P. Acides aminés et trisomie 21. Ann Genet. 1992;35(1):8–13. [PubMed] [Google Scholar]
- Peeters M. A., Poon A., Zipursky A., Lejeune J. Toxicity of leukaemia therapy in children with Down syndrome. Lancet. 1986 Nov 29;2(8518):1279–1279. doi: 10.1016/s0140-6736(86)92704-2. [DOI] [PubMed] [Google Scholar]